loader2
Partner With Us NRI

Pharmaids Pharmaceuticals Ltd share Price Today

Company details

57.35
57.35
28.50
79.23
6M Return 27.44%
1Y Return 89.78%
Mkt Cap.(Cr) 202.26
Volume 4,437
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 4,437

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Pharmaids Pharmaceuticals Ltd shares SWOT Analysis

Strengths (3)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with No Debt
  • Company with Zero Promoter Pledge

Weakness (2)

  • Promoter holding decreased by more than -2% QoQ
  • Low Piotroski Score : Companies with weak financials

Opportunity (2)

  • Highest Recovery from 52 Week Low
  • Stock with Low PE (PE < = 10)

Threats (2)

  • Promoter decreasing their shareholding
  • Companies with growing costs YoY for long term projects

Resistance and support

R1 58.5
R2 58.5
R3 58.5
Pivot

58.49

S1 58.5
S2 58.5
S3 58.5
EMA SMA
56.2
56.3
54.5
48.5
56.8
56.3
57.2
48.7
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
TOPGAIN FINANCE PRIVATE LIMITED Bulk Purchase 2022-12-19 32.42 80000 BSE
EPITOME TRADING AND INVESTMENTS Bulk Purchase 2022-12-19 32.45 75000 BSE
EPITOME TRADING AND INVESTMENTS Bulk Purchase 2022-12-15 29.33 60456 BSE
Name Category Shares
SADHANALA VENKATA RAO PROMOTER 4.4%
PADMAJA KALYANI SADHANALA PROMOTER 0.54%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Pharmaids Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Pharmaids Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Zydus Lifesciences Ltd Divis Laboratories Ltd
Price 57.35 1,531.40 1,399.05 1,051.40 3,910.75
% Change 4.01 0.26 -0.54 5.45 0.47
Mcap Cr 202.26 367,434.16 112,954.68 105,795.44 103,818.29
Revenue TTM Cr 0.00 43,885.68 15,790.60 17,237.40 7,767.51
Net Profit TTM Cr -7.56 8,560.84 2,513.47 1,997.30 1,823.38
PE TTM 0.00 39.15 26.62 28.83 75.36
1 Year Return 89.78 60.69 51.61 103.07 19.36
ROCE 0.00 16.79 14.76 16.25 19.30
ROE 0.00 16.46 10.66 14.05 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 22.11 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 44,248.95 -31,659.16
LAST 3M 105,886.10 -43,482.14
LAST 6M 173,149.22 48,654.40
LAST 12M 264,707.07 127,969.33

Pharmaids Pharmaceuticals Ltd Information

Stock PE (TTM)
0
Promoter Holding
5.64%
Book Value
21.1511
ROCE
0%
ROE
0%
Description
  • Pharmaids Pharmaceuticals Ltd. is an Indian pharmaceutical company that manufactures specialty chemicals, skin care products, hospital care products and bulk drugs. The company was incorporated in 1989 in Hyderabad, Telangana. 

    Under its specialty chemicals segment, it produces products including retinol, DL Alpha Tocopherol, D Pantothenate, Nicotinic Acid, D-Biotin, among others. Its skin care line includes hand sanitisers, moisturising creams, alcohol gels, barrier creams, etc. Its hospital care products consist of a line of hand rubs, gels, skin antiseptic solutions and general antiseptics and disinfectants. Pharmaids Pharmaceuticals Ltd. also produces a range of generic drugs. 

    Pharmaids Pharmaceuticals Ltd. benefits from India’s position in the global pharmaceutical market. Our country is the largest provider of generic drugs globally, supplying over 50% of the world’s vaccines, 40% of generic drugs in the US and 25% of all medicines in the UK. The Indian pharmaceutical sector is forecasted to grow to $100 billion by 2025.

    Pharmaids Pharmaceuticals Ltd. is a small-cap company that is listed on the Bombay Stock Exchange (BSE). The BSE has allotted the number 524572 to the company. 

    The company’s market capitalisation is Rs. 13.66 crores as of 25th March 2022. Pharmaids Pharmaceuticals Ltd. share price as of 24th March 2022 was at Rs. 13.19. Pharmaids Pharmaceuticals Ltd. shares clocked in a 52-week high of Rs. 30.40 and a 52-week low of Rs. 10.27. The company’s price to earnings ratio was 100.36 as of 25th March 2022. In the last year, Pharmaids Pharmaceuticals Ltd. has given investors a return of 20.61%. 

    Pharmaids Pharmaceuticals Ltd. made total revenues of Rs. 72.39 lakhs for the quarter ended 31st December 2021, compared to total revenue of Rs. 3.41 crores for the same period in the previous year. As for its profit, the company recorded a total profit of Rs. 1.42 lakhs for the quarter ended 31st December 2021, compared to Rs. 0.97 lakhs for the same period in the previous year. It posted earnings per share of Rs. 1.42 for the quarter ended 31st December 2021, compared to Rs. 0.97 for the same period in the previous year. 

    Promoters hold 55.56% of Pharmaids Pharmaceuticals Ltd.’s shares, while retail investors own the remaining 44.44%. A majority of the promoter holdings, i.e. 41.74%, are held by one individual – Venkata Bhagi Rao Sadhanala. 

    Disclaimer- ICICI Securities Ltd.( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon.

    The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.

Registered Address

4-4-211/212/3 1st Floor, Inderbagh Sulthan Bazar, Hyderabad, Telangana, 500095

Tel : 91-40-66669809
Email : compliance:pharmaids.com
Website : http://www.pharmaids.com
Registrar

Venture Capital & Corp. Inv.

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524572
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE117D01018

FAQ’s on Pharmaids Pharmaceuticals Ltd Shares

You can buy Pharmaids Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Pharmaids Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 17, 2024 04:01 PM the closing price of Pharmaids Pharmaceuticals Ltd was Rs.57.35.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 17, 2024 04:01 PM, the market cap of Pharmaids Pharmaceuticals Ltd stood at Rs. 202.26.

The latest PE ratio of Pharmaids Pharmaceuticals Ltd as of May 17, 2024 04:01 PM is 0.00

The latest PB ratio of Pharmaids Pharmaceuticals Ltd as of May 17, 2024 04:01 PM is 0.37

The 52-week high of Pharmaids Pharmaceuticals Ltd share price is Rs. 79.23 while the 52-week low is Rs. 28.50

Download App

Download Our App

Play Store App Store
market app